Search Results 701-710 of 11393 for anti-TNF drugs

1. Dacomitinib (oral route) - Side effects & dosage - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Stem Cell Therapy Clinical Trials - Mayo Clinic Research

   ... anti-Crohn's therapy. Six weeks post placement of the draining seton, the seton will be replaced with the MSC loaded Gore® Bio-A® fistula plug as per ...

3. Safety, Efficacy And Tolerability Of Ianalumab Versus Placebo, Combination With SoC Therapy, In Participants With Active Lupus Nephritis - Mayo Clinic

   * Anti-malarial treatment at stable dosing prior ... * Use of other investigational drugs ... * Belimumab, telitacicept, abatacept, TNF-α mAb, immunoglobulins (i.v. ...

4. Sequential Treatments Or Combinations Including Dasatinib, Quercetin, Fisetin And/or Temozolomide For The Treatment Of Previously Treated Glioma With Residual Disease - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... They have antioxidant and anti-inflammatory ... Temozolomide is in a class of medications called alkylating ...

5. New international practice guidelines for tamoxifen treatment based on CYP2D6 genotype - Mayo Clinic News Network

   ... anti-estrogenic potency and anti-tumor activity than the parent drug. Antiestrogens are a class of drugs which prevent estrogens from mediating their ...

6. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Subject is receiving other ongoing anti-myeloma therapy. Subject has received any of the following within 7 days prior to the first dose of study drug:.

7. Clinical trials - Oncology (Medical)

   In addition, obesity, a chronic inflammatory state, is associated with increased colorectal cancer risk (5). However, the use of anti-inflammatory agents in the ...

8. Discovery's Edge: First Cure With a New Drug - Mayo Clinic News Network

   ... drugs he was working on that they might test. The pair had been following his published papers on natural compounds that had anti-bacterial properties. He ...

9. A Phase 3 Clinical Trial Of CCX168 (Avacopan) In Patients With ANCA-Associated Vasculitis

   Drugs & Supplements A-Z · Health Books · Healthy ... Positive test for anti-PR3 or anti-MPO; At least 1 ... TNF treatment, abatacept, alemtuzumab, IVIg ...

10. Researchers seek to improve success of chimeric antigen receptor-T cell therapy in non-Hodgkin lymphoma - Mayo Clinic News Network

    The study is published in Cancer Discovery. "CAR-T cell therapy is a promising treatment for non-Hodgkin lymphoma, especially for patients who have relapsed or ...